about
Zika virus disease: a current review of the literaturePotential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literatureThe relationship between epilepsy and sexual dysfunction: a review of the literatureRights and Responsibilities of Tuberculosis Patients, and the Global Fund: A Qualitative StudyAssessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan.WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan.Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan.Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan.Availability and affordability of biologic versus non-biologic anticancer medicines: a cross-sectional study in Punjab, Pakistan.Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan.Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.Influence of Education Level of Older Patients on Polypharmacy, Potentially Inappropriate Medications Listed in Beer’s Criteria, and Unplanned Hospitalization: A Cross-Sectional Study in Lahore, PakistanAntimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, PakistanAttitude, perception, willingness, motivation and barriers to practice-based research: A cross-sectional survey of hospital pharmacists in Lahore, Punjab, PakistanCapacity and willingness to use information technology for managing chronic diseases among patients: A cross-sectional study in Lahore, Pakistan
P50
Q26261644-78F42F6E-2948-4A3A-A2EF-EA978A9EFE2BQ26749431-F059CD81-B971-4738-8B50-03B2333BD499Q28068847-C081DBC9-B926-446F-B10A-B526F01EE6FFQ28550902-2C4096BD-1CDE-4ED1-A341-F52C1D8726ECQ36216575-C170BF47-AA31-41F7-8F43-0383E2C8DF2BQ37399162-D14767AC-26C9-4DFF-8AA9-BC28F32B8ACFQ41166842-27EA1F88-6DB0-46A9-B6FE-22F393BF3B83Q47097742-E4A91FEF-A32C-4697-BAC2-30B8ADF824A9Q55279429-A51DC77C-6BA9-4237-A9F6-B43F07015465Q55428132-3640BA2D-B7AA-4301-A75C-FD8DAE3935D7Q55513301-208B2C04-23B6-41AB-A4D0-50EA5FEF81C7Q56775092-C5B88FB4-580A-470B-BD47-038F2E989767Q57945162-14DA3132-2E6A-49B8-9BA6-F9FA190E3C7EQ58760015-9CC40B3C-7F41-406D-9AD5-1DD0C3496DADQ61798405-BDB8013C-7579-49A0-8660-E47461F12D9A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Muhammad Rehan Sarwar
@ast
Muhammad Rehan Sarwar
@en
Muhammad Rehan Sarwar
@es
Muhammad Rehan Sarwar
@nl
Muhammad Rehan Sarwar
@sl
type
label
Muhammad Rehan Sarwar
@ast
Muhammad Rehan Sarwar
@en
Muhammad Rehan Sarwar
@es
Muhammad Rehan Sarwar
@nl
Muhammad Rehan Sarwar
@sl
prefLabel
Muhammad Rehan Sarwar
@ast
Muhammad Rehan Sarwar
@en
Muhammad Rehan Sarwar
@es
Muhammad Rehan Sarwar
@nl
Muhammad Rehan Sarwar
@sl
P106
P1153
57146857700
P21
P31
P496
0000-0003-4312-9157